The negative outlook reflects the hospital’s significant inpatient volume decline in fiscal year 2018 and history of volume declines, which have constrained revenue growth.
S&P affirmed its “BB+” long-term rating for the hospital.
More articles on healthcare finance:
Shifting to value-based approach best way to reduce health costs, says AMGA
For-profit hospital stock report: Week of Feb. 25-March 1
California health data company’s 138% stock jump a mystery to traders